NA
QCOR

Navellier & Associates’s QUESTCOR PHARMA INC QCOR Stock Holding History

Navellier & Associates’s Portfolio QCOR Stock Details QCOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-8,742
Closed -$568K – 377
2014
Q1 		$568K Buy
+8,742
New +$558K 0.03% 154
2013
Q4 		– Sell
-6,639
Closed -$385K – 348
2013
Q3 		$385K Buy
6,639
+780
+13% +$46.4K 0.01% 211
2013
Q2 		$266K Buy
+5,859
New +$208K 0.01% 224

Other funds holding QCOR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Navellier & Associates's QCOR Position: Q2 2014 in Review

Navellier & Associates sold out of QUESTCOR PHARMA INC (QCOR) in Q2 2014, closing a stake of 8,742 shares — an estimated $568K sold.

Navellier & Associates first reported a position in QCOR in Q2 2013 and held it in 3 quarters. The position peaked at $568K in Q1 2014. 320 funds tracked by Wall St. Rank hold QCOR as of Q2 2014.

  • Navellier & Associates reported no remaining QUESTCOR PHARMA INC position as of Q2 2014 after selling out during the quarter.
  • Navellier & Associates sold 8,742 QUESTCOR PHARMA INC shares in Q2 2014, an estimated $568K.
  • Navellier & Associates first reported a position in QUESTCOR PHARMA INC in Q2 2013 and held it in 3 quarters.
  • Navellier & Associates's QUESTCOR PHARMA INC position peaked at $568K in Q1 2014.
  • 320 funds tracked by Wall St. Rank held QUESTCOR PHARMA INC as of Q2 2014.

Based on Navellier & Associates's 13F filing for Q2 2014, filed 9 Jul 2014.